MarketPeel
Insider Trading Intelligence
BE

Badreddin Edris

EWTX
DIRECTOR · EDGEWISE THERAPEUTICS, INC. · CIK 0001786966
FILING MIX · LIFETIME52%/48%
BUYS
11
SELLS
10
TOTAL VALUE
$3.57M
COMPANIES
1
ACTIVE SINCE
Jun 2022
HOLDINGS NOW
5,619
AVG SELL PX
$29.44
TRADE KIND
SHOWING 21 / 21
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Badreddin Edris, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%-1.92%+1.46%-3.38%-3.38%
14d5+100.00%-2.63%+0.12%-2.75%-2.75%
30d5+0.00%+0.24%+0.59%-0.35%-0.35%
60d5+0.00%+1.92%-4.38%+6.29%+6.29%
90d5+0.00%+10.98%+2.73%+8.25%+8.25%
180d5(5 pending)
1y5(5 pending)
2y5(5 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EWTX · 5,619 shares · as of Jun 5, 2026
033,82367,646101,468135,2912023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 10 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,6195,619Jun 5, 2026Jun 16, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,1888,188Jun 5, 2026Jun 16, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,690$29.44$403.0K121,601Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
66,477$29.44$1.96M19,820Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
7,605$0.71$5.4K135,291Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
66,4770Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
17,236$0.64$11.0K50,746Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
66,477$1.93$128.3K127,686Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,463$29.44$308.0K86,297Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
17,2360Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
7,6050Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
13,6900Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,236$29.44$507.4K104,365Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
10,463$1.93$20.2K61,209Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASE
13,690$0.39$5.3K33,510Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
7,605$29.44$223.9K96,760Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
SALE
10,4630Jan 21, 2026Jan 21, 2026View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Jun 16, 2025Jun 18, 2025View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,59420,594Jun 10, 2024Jun 12, 2024View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,12322,123Jun 12, 2023Jun 14, 2023View →
EWTX
EDGEWISE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
42,08742,087Jun 24, 2022Jun 28, 2022View →
Other insiders · EWTX
Loading peer insiders…
About this filer
CIK 0001786966
ROLE
Director
PRIMARY
EWTX
COMPANIES
1
ACTIVE SINCE
Jun 2022
MARKETPEEL · /INSIDER/0001786966DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback